##################################################################################
# Document Properties
##################################################################################
SET DOCUMENT Name = "Huang_et.al_2020.bel"
SET DOCUMENT Authors = "Thrishna"
SET DOCUMENT ContactInfo = "thrishna@causalitybiomodels.com"
SET DOCUMENT Description = "COVID Knowledge Curation project"

SET DOCUMENT Licenses = "Private Ownership to Fraunhofer Institute SCAI"
SET DOCUMENT Copyright = "Copyright Â© 2020 Fraunhofer Institute SCAI, All rights reserved"
SET DOCUMENT Version = "2.0.0"


##################################################################################
# NAMESPACES Section
##################################################################################

DEFINE NAMESPACE COVID AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns"
DEFINE NAMESPACE CHEBI AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns"
DEFINE NAMESPACE HGNC AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns"
DEFINE NAMESPACE PUBCHEM AS PATTERN "^\d+$"

DEFINE ANNOTATION BioAssay AS PATTERN ".*"

# Document Annotations #
DEFINE ANNOTATION PublicationType AS LIST {"Research"}
DEFINE ANNOTATION PublicationStatus AS LIST {"Preprint"}
DEFINE ANNOTATION Section AS LIST {"Results"}
##################################################################################
# Statements #
##################################################################################
#example#
SET Citation = {"DOI", "XXX"}
SET PublicationType = "Research"
SET PublicationStatus = "Preprint"
SET Section = "Results"
SET BioAssay = "molecular docking"
SET Evidence = "GS-5734, a well-known RdRp inhibitor,23 shown a moderate dock score of \
36.24."

a(PUBCHEM:121304016) -| p(COVID:ORF1ab, frag("4393_5324"))
complex(a(PUBCHEM:121304016), p(COVID:ORF1ab, frag("4393_5324")))

SET Evidence = "Data in Table1 showed that some molecules with top similarity to \
GS-5734 got high dock scores (Atorvastatin, Dipyridamole, and \
Adenosine)."

complex(a(CHEBI:atorvastatin), p(COVID:ORF1ab, frag("4393_5324")))
complex(a(CHEBI:dipyridamole), p(COVID:ORF1ab, frag("4393_5324")))
complex(a(CHEBI:adenosine), p(COVID:ORF1ab, frag("4393_5324")))

SET Evidence = "Decitabine has the most favorable docking results."

complex(a(CHEBI:"5-aza-2'-deoxycytidine"), p(COVID:ORF1ab, frag("4393_5324")))

SET Evidence = "After docked with library A, finally 12 approved drugs with good \
docking score were chosen (Table 3), and 3 of them were selected for \
further binding free energy calculations"

complex(a(CHEBI:fenofibrate), p(COVID:ORF1ab, frag("819_2763")))
complex(a(CHEBI:cinchocaine), p(COVID:ORF1ab, frag("819_2763")))
complex(a(CHEBI:tamsulosin), p(COVID:ORF1ab, frag("819_2763")))
complex(a(CHEBI:pentamidine), p(COVID:ORF1ab, frag("819_2763")))
complex(a(CHEBI:tolazamide), p(COVID:ORF1ab, frag("819_2763")))
complex(a(CHEBI:gemeprost), p(COVID:ORF1ab, frag("819_2763")))
complex(a(CHEBI:"1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester"), p(COVID:ORF1ab, frag("819_2763")))
complex(a(CHEBI:rilpivirine), p(COVID:ORF1ab, frag("819_2763")))
complex(a(CHEBI:ampicillin), p(COVID:ORF1ab, frag("819_2763")))
complex(a(PUBCHEM:9865604), p(COVID:ORF1ab, frag("819_2763")))
complex(a(CHEBI:methicillin), p(COVID:ORF1ab, frag("819_2763")))
complex(a(CHEBI:omeprazole), p(COVID:ORF1ab, frag("819_2763")))
#docing study conduced in PLpro.

SET Evidence = "12 representative drugs were listed in Table 5."

complex(a(CHEBI:icatibant), p(COVID:ORF1ab, frag("3264_3569")))
complex(a(CHEBI:ritonavir), p(COVID:ORF1ab, frag("3264_3569")))
complex(a(CHEBI:colistin), p(COVID:ORF1ab, frag("3264_3569")))
complex(a(CHEBI:atazanavir), p(COVID:ORF1ab, frag("3264_3569")))
complex(a(CHEBI:valinomycin), p(COVID:ORF1ab, frag("3264_3569")))
complex(a(CHEBI:tipranavir), p(COVID:ORF1ab, frag("3264_3569")))
complex(a(CHEBI:lopinavir), p(COVID:ORF1ab, frag("3264_3569")))
complex(a(CHEBI:indinavir), p(COVID:ORF1ab, frag("3264_3569")))
complex(a(CHEBI:darunavir), p(COVID:ORF1ab, frag("3264_3569")))
complex(a(CHEBI:simeprevir), p(COVID:ORF1ab, frag("3264_3569")))
complex(a(CHEBI:sorafenib), p(COVID:ORF1ab, frag("3264_3569")))
complex(a(CHEBI:"glycyrrhizinic acid"), p(COVID:ORF1ab, frag("3264_3569")))
#3CLpro Docking


SET Evidence = "The results shown that 13 representative drugs got higher docking \
scores than intrinsic ligand, which may be potential AKK1 inhibitor."

#(Table 7)
complex(a(CHEBI:"desferrioxamine B"), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))
complex(a(CHEBI:erlotinib), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))
complex(a(CHEBI:ceftolozane), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))
complex(a(PUBCHEM:4677), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))
#Pantethine
complex(a(CHEBI:hesperidin), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))
complex(a(CHEBI:carfilzomib), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))
complex(a(CHEBI:saquinavir), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))
complex(a(CHEBI:penicillamine), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))
complex(a(CHEBI:ticagrelor), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))
complex(a(CHEBI:zafirlukast), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))
complex(a(CHEBI:daclatasvir), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))
complex(a(CHEBI:sorafenib), p(HGNC:AAK1)) -| act(p(HGNC:AAK1))

#AAK1 docking study
UNSET BioAssay
UNSET PublicationType
UNSET PublicationStatus
UNSET Section
UNSET Citation
